North American Sexually Transmitted Diseases (STD) Diagnostics Market, Size, Share, Analysis Report & Forecast to 2026

North American STD diagnostics market is growing at a CAGR of around 8.2% during the forecast period. North America is considered to be the dominating country due to various factors such as R&D, high healthcare expenditure, rising number of STD patients. North America has one of the strongest economies globally, as it comprises more than 27.8% of the world’s economy as per World Economic Forum. North American STD diagnostics market comprises two countries including the US and Canada. North America spends almost 17.20% of GDP on healthcare expenditure, whereas Canada spends 10.60% of GDP on healthcare. Accordingly, the expenditure rate of the US is more than Canada, as the country invests more on R&D and there are ample of opportunities. The major factors that are driving the North American STD diagnostics market include rising healthcare spending, R&D investments, high quality of healthcare infrastructure, demand for treatment and care and other factors.

Free Sample Copy @ https://www.omrglobal.com/request-sample/north-american-sexually-transmitted-disease-market

Further, the presence of the key players such as Abbott Laboratories, Inc., Becton, Dickinson and Co., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific, Inc. among others are also affecting the North American STD diagnostics market. The STD diagnostics key players are adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others in order to thrive in a competitive environment.

A Full Report of North American Sexually Transmitted Diseases (STD) Diagnostics Market is Available at:
https://www.omrglobal.com/industry-reports/north-american-sexually-transmitted-disease-market

For instance, In January 2018, Bio-Rad announced that it received 510(k) clearances from the U.S. Food and Drug Administration (FDA) for the IH-Incubator L and IH-Centrifuge L instruments to be used with the full range of Bio-Rad’s IH-System Gel Reagents for manual blood typing methods. Whereas, in july, 2017 BIOMERIEUX has received 510(k) clearances from FDA for enhanced pathogen detection capability on VITEK MS. The VITEK MS system’s newly expanded database and Mycobacterium/Nocardia and Moulds reagent kits in the US.

North American Sexually Transmitted Diseases (STD) Diagnostics Market – Segmentation
by Disease Type
Chlamydia
Syphilis
Gonorrhea
Herpes Simplex Virus (HSV)
Human Papilloma Virus (HPV)
Human Immunodeficiency Virus (HIV)
Others
by Product
Laboratory Testing Devices
Point-of-Care (POC) Testing Devices
by End-user
Hospitals and Clinics
Diagnostic Centers
Homecare

North American Sexually Transmitted Diseases (STD) Diagnostics Market – Segmentation by Region 
United States
Canada

Company Profiles
Abbott Laboratories, Inc.
AbbVie Inc.
Becton, Dickinson and Co.
Biocartis NV
Bio-Rad Laboratories, Inc.
Danaher Corp.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Merck KGaA
Thermo Fisher Scientific, Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-sexually-transmitted-disease-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com 
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.